Weight Loss, HbA1c Reduction, and Tolerability of Cetilistat in a Randomized, Placebo‐controlled Phase 2 Trial in Obese Diabetics: Comparison With Orlistat (Xenical)
Year: 2009
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: Obesity
DOI: 10.1038/oby.2009.155
Authors: Peter Kopelman, H. Gerrit de Groot, Aila Rissanen, Stephan Rossner, Soren Toubro, Richard Palmer, Rob Hallam, Andrew Bryson, Roger I. Hickling
Language: English
Subfield: Pharmacology (medical)
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2154256486
